Brief: Sanuwave Health Enters Into Merger Deal With Sweat Equity Partners And Mercury Life Sciences-Affiliated Sep Acquisition Corp

SANUWAVE Health

23/08/2023 22:14

Aug 23 (Reuters) - SEP Acquisition Corp  SEPA.O :
    * SANUWAVE HEALTH, INC., A LEADING PROVIDER OF FDA APPROVED
NEXT-GENERATION WOUND CARE PRODUCTS, ENTERS INTO A MERGER
AGREEMENT WITH SWEAT EQUITY PARTNERS AND MERCURY LIFE
SCIENCES-AFFILIATED SEP ACQUISITION CORP., A NASDAQ-LISTED
COMPANY
    * SEP ACQUISITION CORP - PROPOSED BUSINESS COMBINATION
VALUES
COMBINED COMPANY AT A PRO FORMA ENTERPRISE VALUE OF $127.5
MILLION
    * SEP ACQUISITION CORP - COMBINED COMPANY EXPECTS TO RECEIVE
ABOUT
$13.0 MILLION OF GROSS PROCEEDS AT CLOSING
    * SEP ACQUISITION CORP - COMBINED COMPANY IS EXPECTED TO
TRADE ON
NASDAQ CAPITAL MARKET UNDER SYMBOL "SNWV"
    * SEP ACQUISITION CORP - UPON COMPLETION OF PROPOSED
TRANSACTION,
COMBINED COMPANY IS EXPECTED TO OPERATE UNDER SANUWAVE NAME
    * SEP ACQUISITION CORP - FUNDING IS EXPECTED TO BE ANCHORED
BY
INVESTORS AFFILIATED WITH SWEAT EQUITY PARTNERS AND MERCURY LIFE
SCIENCES

Source text for Eikon:  ID:nGNX26QTJt 
Further company coverage:  SEPA.O 

 ((Reuters.Briefs@thomsonreuters.com;))